EJU0 Stock Overview
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Aethlon Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.25 |
| 52 Week High | US$4.19 |
| 52 Week Low | US$1.25 |
| Beta | 1.94 |
| 1 Month Change | -19.35% |
| 3 Month Change | -21.38% |
| 1 Year Change | -62.35% |
| 3 Year Change | -91.61% |
| 5 Year Change | n/a |
| Change since IPO | -92.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| EJU0 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -6.7% | 2.6% | 1.2% |
| 1Y | -62.3% | -8.3% | 2.0% |
Return vs Industry: EJU0 underperformed the German Medical Equipment industry which returned -8.3% over the past year.
Return vs Market: EJU0 underperformed the German Market which returned 2% over the past year.
Price Volatility
| EJU0 volatility | |
|---|---|
| EJU0 Average Weekly Movement | 5.6% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: EJU0's share price has been volatile over the past 3 months.
Volatility Over Time: EJU0's weekly volatility has decreased from 109% to 6% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 15 | Jim Frakes | www.aethlonmedical.com |
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.
Aethlon Medical, Inc. Fundamentals Summary
| EJU0 fundamental statistics | |
|---|---|
| Market cap | €3.33m |
| Earnings (TTM) | -€11.45m |
| Revenue (TTM) | €536.80k |
6.2x
P/S Ratio-0.3x
P/E RatioIs EJU0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EJU0 income statement (TTM) | |
|---|---|
| Revenue | US$574.25k |
| Cost of Revenue | US$0 |
| Gross Profit | US$574.25k |
| Other Expenses | US$12.82m |
| Earnings | -US$12.25m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.67 |
| Gross Margin | 100.00% |
| Net Profit Margin | -2,133.18% |
| Debt/Equity Ratio | 0% |
How did EJU0 perform over the long term?
See historical performance and comparison